Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking

Overview

Journal Front Pharmacol

Date 2021 Dec 16

PMID 34912216

Citations 20

Authors

Wei Zou

Birui Shi

Ting Zeng

Yan Zhang

Baolin Huang

Bo Ouyang

Zheng Cai

Menghua Liu

Affiliations

Soon will be listed here.

Abstract

The kidneys are a pair of important organs that excretes endogenous waste and exogenous biological agents from the body. Numerous transporters are involved in the excretion process. The levels of these transporters could affect the pharmacokinetics of many drugs, such as organic anion drugs, organic cationic drugs, and peptide drugs. Eleven drug transporters in the kidney (OAT1, OAT3, OATP4C1, OCT2, MDR1, BCRP, MATE1, MATE2-K, OAT4, MRP2, and MRP4) have become necessary research items in the development of innovative drugs. However, the levels of these transporters vary between different species, sex-genders, ages, and disease statuses, which may lead to different pharmacokinetics of drugs. Here, we review the differences of the important transports in the mentioned conditions, in order to help clinicians to improve clinical prescriptions for patients. To predict drug-drug interactions (DDIs) caused by renal drug transporters, the molecular docking method is used for rapid screening of substrates or inhibitors of the drug transporters. Here, we review a large number of natural products that represent potential substrates and/or inhibitors of transporters by the molecular docking method.

Citing Articles

Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.

Wu K, Kwon S, Zhou X, Fuller C, Wang X, Vadgama J Int J Mol Sci. 2024; 25(23.

PMID: 39684832 PMC: 11642056. DOI: 10.3390/ijms252313121.

Embracing sex-specific differences in engineered kidney models for enhanced biological understanding of kidney function.

Veser C, Carlier A, Dubois V, Mihaila S, Swapnasrita S Biol Sex Differ. 2024; 15(1):99.

PMID: 39623463 PMC: 11613810. DOI: 10.1186/s13293-024-00662-8.

Modulation of Multispecific Transporters by Extract and Its Major Phytoconstituents.

Szilvasy N, Lajer P, Horvath A, Veres K, Hohmann J, Schelz Z Pharmaceutics. 2024; 16(11).

PMID: 39598486 PMC: 11597817. DOI: 10.3390/pharmaceutics16111363.

Recent Advances on the Regulations of Organic Anion Transporters.

Yu Z, You G Pharmaceutics. 2024; 16(11).

PMID: 39598479 PMC: 11597148. DOI: 10.3390/pharmaceutics16111355.

Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney.

Pan Y, Yang Z, Wei M, Gan Y, Liu M, Zou W Eur J Drug Metab Pharmacokinet. 2024; 50(1):39-51.

PMID: 39522097 DOI: 10.1007/s13318-024-00923-2.

References

Koepsell H . Polyspecific organic cation transporters and their biomedical relevance in kidney. Curr Opin Nephrol Hypertens. 2013; 22(5):533-8. DOI: 10.1097/MNH.0b013e328363ffaf. View

Su Q, Su H, Nong Z, Li D, Wang L, Chu S . Hypouricemic and Nephroprotective Effects of an Active Fraction from Polyrhachis Vicina Roger On Potassium Oxonate-Induced Hyperuricemia in Rats. Kidney Blood Press Res. 2018; 43(1):220-233. DOI: 10.1159/000487675. View

Zuo T, Chen P, Jing S, Zhang T, Chang L, Xu F . Quantitative Proteomics Reveals the Development of HBV-Associated Glomerulonephritis Triggered by the Downregulation of SLC7A7. J Proteome Res. 2020; 19(4):1556-1564. DOI: 10.1021/acs.jproteome.9b00799. View

Wan Z, Song L, Hu L, Lei X, Huang Y, Lv Y . Temporal trends in hyperuricaemia among adults in Wuhan city, China, from 2010 to 2019: a cross-sectional study. BMJ Open. 2021; 11(3):e043917. PMC: 8016088. DOI: 10.1136/bmjopen-2020-043917. View

Feng Y, Sun F, Gao Y, Yang J, Wu G, Lin S . Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injury. Biochem Biophys Res Commun. 2017; 489(3):312-318. DOI: 10.1016/j.bbrc.2017.05.139. View

Sengupta P . The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med. 2013; 4(6):624-30. PMC: 3733029. View

Taniguchi T, Omura K, Motoki K, Sakai M, Chikamatsu N, Ashizawa N . Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2. Sci Rep. 2021; 11(1):7232. PMC: 8012596. DOI: 10.1038/s41598-021-86662-9. View

Al-Majdoub Z, Achour B, Couto N, Howard M, Elmorsi Y, Scotcher D . Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin. FEBS Lett. 2020; 594(23):4134-4150. PMC: 7756589. DOI: 10.1002/1873-3468.13982. View

Goyal S, Reddy N, Patil K, Nakhate K, Ojha S, Patil C . Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact. 2015; 244:49-63. DOI: 10.1016/j.cbi.2015.11.032. View

10.

Xu Y, Liu X, Wang Y, Zhou N, Peng J, Gong L . Combinatorial Pharmacophore Modeling of Multidrug and Toxin Extrusion Transporter 1 Inhibitors: a Theoretical Perspective for Understanding Multiple Inhibitory Mechanisms. Sci Rep. 2015; 5:13684. PMC: 4556958. DOI: 10.1038/srep13684. View

11.

Hull R, Goldsmith D . Nephrotic syndrome in adults. BMJ. 2008; 336(7654):1185-9. PMC: 2394708. DOI: 10.1136/bmj.39576.709711.80. View

12.

Gottier Nwafor J, Nowik M, Anzai N, Endou H, Wagner C . Metabolic Acidosis Alters Expression of Slc22 Transporters in Mouse Kidney. Kidney Blood Press Res. 2020; 45(2):263-274. DOI: 10.1159/000506052. View

13.

Canet M, Hardwick R, Lake A, Dzierlenga A, Clarke J, Goedken M . Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis. Drug Metab Dispos. 2014; 43(2):266-72. PMC: 4293398. DOI: 10.1124/dmd.114.060574. View

14.

Kim H, Lim S, Jin L, Jin J, Chung B, Yang C . The Protective Effect of Febuxostat on Chronic Tacrolimus-Induced Nephrotoxicity in Rats. Nephron. 2016; 135(1):61-71. DOI: 10.1159/000449289. View

15.

Garg P, Dhakne R, Belekar V . Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability. Mol Divers. 2014; 19(1):163-72. DOI: 10.1007/s11030-014-9562-2. View

16.

Abdussalam A, Elshenawy O, Bin Jardan Y, El-Kadi A, Brocks D . The Obesogenic Potency of Various High-Caloric Diet Compositions in Male Rats, and Their Effects on Expression of Liver and Kidney Proteins Involved in Drug Elimination. J Pharm Sci. 2017; 106(6):1650-1658. DOI: 10.1016/j.xphs.2017.02.002. View

17.

Karimian Pour N, Piquette-Miller M . Endotoxin Modulates the Expression of Renal Drug Transporters in HIV-1 Transgenic Rats. J Pharm Pharm Sci. 2018; 21(1s):117s-129s. DOI: 10.18433/jpps30017. View

18.

Ferreira R, Baptista R, Moreno A, Madeira P, Khonkarn R, Baubichon-Cortay H . Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters. Future Med Chem. 2018; 10(7):725-741. DOI: 10.4155/fmc-2017-0228. View

19.

Soetikno V, Sari S, Ul Maknun L, Sumbung N, Rahmi D, Pandhita B . Pre-Treatment with Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats. Drug Res (Stuttg). 2018; 69(2):75-82. DOI: 10.1055/a-0641-5148. View

20.

Fang Y, Cao W, Liang F, Xia M, Pan S, Xu X . Structure affinity relationship and docking studies of flavonoids as substrates of multidrug-resistant associated protein 2 (MRP2) in MDCK/MRP2 cells. Food Chem. 2019; 291:101-109. DOI: 10.1016/j.foodchem.2019.03.111. View